Entities / Company
Rallybio.
American biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 15
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ days-
Rallybio and Standard BioTools Inc. are currently involved in merger investigations.Some support1 report
-
Recursion Pharmaceuticals acquired Rallybio's joint venture stake.Some support5 reports
-
Jon Lieber was appointed to the Board of Directors of ImmunoPrecise Antibodies Ltd. on July 7, 2025.Speculative1 report
-
Rallybio and Recursion initiated preclinical studies for the compound REV102.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Rallybio this week
News at the entities that move Rallybio most-
MarketBeat Mentioned togetherMarketBeat reported the consensus stock rating for Wheeler Real Estate Investment Trust, Inc.Moves Rallybio
-
New Haven Shared contextMayor Elicker announced a redesign project linking downtown to the East Rock neighborhood, emphasizing safety.Moves Rallybio
Connections
The 3 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Standard BioTools Inc. Mentioned together
Both companies are currently involved in merger investigations.
-
MarketBeat Mentioned together
MarketBeat reports analyst recommendations, placing Rallybio within its scope of financial data coverage.
-
New Haven Shared context
Rallybio is headquartered and operates from New Haven, Connecticut.
History
Events by the month they beganJuly 2026
1 eventJune 2026
4 events- Trump's oil and gas pledges benefit US stocks, specifically impacting Pfizer.
- Recursion Pharmaceuticals acquired Rallybio's joint venture stake.
- Jon Lieber was appointed to the Board of Directors of ImmunoPrecise Antibodies Ltd. on July 7, 2025.
- Rallybio and Recursion initiated preclinical studies for the compound REV102.